Tecnotree Recognized as Representative Vendor in Gartner Market Guide for CSP Customer Management and Experience Solutions
Tecnotree, a global digital platform and services leader for 5G, IOT, and cloud-native technology, announced that it has been named as a representative vendor in the 2022 Gartner Market Guide for CSP Customer Management and Experience Solutions.
The Gartner report is authored by analysts Juha Korhonen, Amresh Nandan, Chris Meering, and Susan Welsh de Grimaldo. It focuses on two major components of Customer Management and Experience (CM&X) solutions, which benefit CSPs immensely. The Gartner market guide enables CSPs to understand market trends & sourcing strategies and keep up with the evolving CM&X solutions. It helps them transform themselves with advancing digital technologies, which further empowers them to manage different aspects of BSS (Business Support Systems), such as customers, services, products, and partners.
Tecnotree has been featured in Gartner for its complete range of CM&X solutions, which includes CRM solutions, self-care apps, product catalogue, customer management, customer journey orchestration, partner management, loyalty programs, Diwa Fintech platform, and for its multi-experience B2B2X ecosystem marketplace platform called Tecnotree Moments, which uses Azure and AWS cloud infrastructure with multitenant capabilities. The Surge, low/no-code platform provides intelligence-enabled customer experience and business orchestration capabilities that can be coupled with moments marketplace capabilities and core digital BSS functionality, that can drive IoT and 5G monetization and automation utilizing mutli-cloud technologies.
Tecnotree solutions assist customers on a BSS transformation journey from being a traditional Communications Services Provider (CSP) to a Digital Services Provider (DSP). With over 44 TM Forum Open APIs deployed for customer management, product and order management, partner management, rating & charging, billing and ecosystem management, Tecnotree helps in providing a complete Digital transformation as well as specific transformation related to customer experience and management. Tecnotree’s cloud-native, AI/ML enabled, and 5G-ready customer experience solutions include cutting-edge digital products. The Gartner report mentions that Tecnotree has implemented several of the TM Forum APIs for CM&X and is among the leading vendors in TM Forum Open APIs certification. The report further recognises the platform that employs a micro-services-based architecture with a unified product catalogue that facilitates customer onboarding, allows converged billing, launches multi-experience bundled offerings, and provides a 360-degree customer view through its patented “profile of one” technology.
‘We are pleased to be recognized in Gartner’s prestigious market guide for our CSP customer management and experience solutions for 2023 again in addition to the recognition that we already received for Revenue Management & Monetization in Q4 of 2022. Our AI-driven CSP solutions meet the rapidly evolving business needs and create 5G revenue opportunities for CSPs, enabling them to provide greater services across various functions. We offer our valued customers increased convenience and unlimited access to world-class products and solutions.’ said Padma Ravichander, CEO-Tecnotree.
She commented further, ‘Our consistent year-on-year inclusion in the Gartner market guide validates our position as being customer-focused in creating digital experiences and revolutionizing enterprise experience through ecosystem partnerships for new-age digital services in a consistent manner.’
About Tecnotree
Tecnotree is a 5G-ready digital Business Support System (BSS) player, with AI/ML capabilities and multi-cloud extensibility. Tecnotree is among the first companies in the world to be Platinum Certified by TM Forum Open API standards, and our agile and open-source Digital BSS Stack comprises the full range (order-to-cash) of business processes and subscription management for telecom and other digital services industries creating opportunities beyond connectivity. Tecnotree also provides Fintech and B2B2X multi-experience digital marketplace to its subscriber base through the Tecnotree Moments platform to empower digitally connected communities across gaming, health, education, OTT, and other vertical ecosystems. Tecnotree is listed on Helsinki Nasdaq (TEM1V).
Gartner Disclaimer
Gartner does not endorse any vendor, product, or service depicted in our research publications and does not advise technology users to select only those vendors with the highest ratings or other designations. Gartner’s research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230413005460/en/
Contact information
Padma Ravichander, Tecnotree CEO
Email: marketing@tecnotree.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release
Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom